This page lists the SEC filings reported by Orbimed Advisors.
| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13G/A | 2001-11-01 | ORBIMED ADVISORS LLC | PRAECIS PHARMACEUTICALS INC | 2,483,700 | 4.9% | EDGAR |
| SC 13G | 2001-11-01 | ORBIMED ADVISORS LLC | ARGONAUT TECHNOLOGIES INC | 963,200 | 5.0% | EDGAR |
| SC 13G | 2001-11-01 | ORBIMED ADVISORS LLC | TRIANGLE PHARMACEUTICALS INC | 4,942,000 | 6.4% | EDGAR |
| SC 13G | 2001-11-01 | ORBIMED ADVISORS LLC | GIVEN IMAGING LTD | 3,936,518 | 15.7% | EDGAR |
| SC 13G/A | 2001-10-04 | ORBIMED ADVISORS LLC | SANGSTAT MEDICAL CORP | 975,300 | 4.7% | EDGAR |
| SC 13G | 2001-10-04 | ORBIMED ADVISORS LLC | INCYTE GENOMICS INC | 3,354,300 | 5.1% | EDGAR |
| SC 13G/A | 2001-09-10 | ORBIMED ADVISORS LLC | ENCHIRA BIOTECHNOLOGY CORP | 0 | 0.0% | EDGAR |
| SC 13D | 2001-08-16 | ORBIMED ADVISORS LLC | DEPOMED INC | 2,497,816 | 20.6% | EDGAR |
| SC 13G | 2001-08-10 | ORBIMED ADVISORS LLC | ALEXION PHARMACEUTICALS INC | 950,000 | 5.2% | EDGAR |
| SC 13G | 2001-07-19 | ORBIMED ADVISORS LLC | LIFECELL CORP | 3,656,250 | 17.3% | EDGAR |
- Form 13F-HR
- The 13F-HR report is filed quarterly to report securities held by the filer that fall under the SEC's 13F rules.
- Form SC 13D/G
- Reported by persons and groups who own 5% or more of any class of a company's outstanding shares. If the ownership changes by 1% or more, an amendment must be filed.
- Form 3, 4, and 5
- Form 3, 4, and 5 reports are filed to report insider transactions by company officers and directors, and any beneficial owners of more than ten percent of a company's shares. Form 3 is the initial report that must be filed when a person becomes an officer, director, or beneficial owner. Form 4 reports are used to report changes in ownership, while the Form 5 report is used for reporting transactions that should have been reported earlier in a Form 4 filing.